— Know what they know.
Not Investment Advice
Also trades as: AUP.TO (TSX) · $vol 4M

AUPH NASDAQ

Aurinia Pharmaceuticals Inc.
1W: +3.3% 1M: +3.6% 3M: +13.9% YTD: +11.0% 1Y: +47.1% 3Y: +128.1% 5Y: -13.5%
$17.25
+0.21 (+1.23%)
 
Weekly Expected Move ±3.3%
$16 $16 $17 $17 $18
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 71 · $2.3B mcap · 129M float · 0.941% daily turnover · Short 45% of daily vol
Credit Risk of going bust: lower than 86% of companies Debt: 2.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.04 (down 99.8%), Aurinia Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $60.4M against a stock market value of $2.27B.
Distance to default 11.63 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $30.2M (short-term plus half of long-term), stock volatility 37.5%; Altman Z'' 6.35. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☀️
Sunny
+22.6% YTD avg
Midterm Year
⛈️
Stormy
-30.7% YTD avg
2026 Now
☀️
Sunny
Below typical
20yr Avg YTD
+22.6%
Day 206 of 252
Midterm Year YTD
-30.7%
Presidential cycle avg
2026 YTD
+12.4%
Below 20yr avg
Typical Vol
73%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+2.3%
Midterm
⛈️
-10.8%
33% win 81% vol
Feb
20yr
💨
+8.0%
Midterm
⛈️
-14.4%
50% win 74% vol
Mar
20yr
💨
+20.2%
Midterm
⛈️
-13.1%
50% win 82% vol
Apr
20yr
🌫️
+18.5%
Midterm
⛈️
-18.0%
67% win 46% vol
May
20yr
⛈️
+13.8%
Midterm
⛈️
-15.2%
50% win 66% vol
Jun
20yr
⛈️
+12.5%
Midterm
⛈️
-16.6%
50% win 50% vol
Jul
20yr
💨
+18.7%
Midterm
⛈️
-25.4%
58% win 63% vol
Aug
20yr
⛈️
+13.2%
Midterm
⛈️
-23.3%
58% win 86% vol
Sep
20yr
💨
+17.7%
Midterm
⛈️
-14.8%
46% win 52% vol
Oct
20yr
💨
+26.0%
Midterm
⛈️
-26.2%
62% win 73% vol
Now: +6.5%
Nov
20yr
💨
+18.9%
Midterm
⛈️
-31.1%
58% win 79% vol
Dec
20yr
💨
+9.3%
Midterm
⛈️
-4.5%
42% win 99% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +12.4%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms